The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency.
about
CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-BChemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytesEpithelial cells in fetal intestine produce chemerin to recruit macrophagesRole of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skinSynthetic chemerin-derived peptides suppress inflammation through ChemR23The genetic design of signaling cascades to record receptor activationPhysiological Roles of Adipokines, Hepatokines, and Myokines in RuminantsChemerin: A comprehensive review elucidating the need for cardiovascular researchChemR23 dampens lung inflammation and enhances anti-viral immunity in a mouse model of acute viral pneumoniaUpdate on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7Molecular evolution of a peptide GPCR ligand driven by artificial neural networksChemerin is an antimicrobial agent in human epidermis.Development of a membrane-anchored chemerin receptor agonist as a novel modulator of allergic airway inflammation and neuropathic painChemerin C9 peptide induces receptor internalization through a clathrin-independent pathwayChemerin, a novel adipokine in the regulation of angiogenesis.Chemerin aggravates DSS-induced colitis by suppressing M2 macrophage polarization.Chemerin-derived peptide C-20 suppressed gonadal steroidogenesis.The chemerin/ChemR23 system does not affect the pro-inflammatory response of mouse and human macrophages ex vivo.Proteolytic activation of prochemerin by kallikrein 7 breaks an ionic linkage and results in C-terminal rearrangement.Elastase and tryptase govern TNFα-mediated production of active chemerin by adipocytes.Chemerin and vaspin: possible targets to treat obesity?The adipokine chemerin amplifies electrical field-stimulated contraction in the isolated rat superior mesenteric arteryChemerin Elicits Potent Constrictor Actions via Chemokine-Like Receptor 1 (CMKLR1), not G-Protein-Coupled Receptor 1 (GPR1), in Human and Rat Vasculature.Adipokine Chemerin Bridges Metabolic Dyslipidemia and Alveolar Bone Loss in Mice.Anti-TNF therapy reduces serum levels of chemerin in rheumatoid arthritis: a new mechanism by which anti-TNF might reduce inflammation.Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual propertiesEvidence from studies in rodents and in isolated adipocytes that agonists of the chemerin receptor CMKLR1 may be beneficial in the treatment of type 2 diabetes.Proteolytic cleavage of chemerin protein is necessary for activation to the active form, Chem157S, which functions as a signaling molecule in glioblastoma.Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis.Signaling Properties of Chemerin Receptors CMKLR1, GPR1 and CCRL2.Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammationChemerin reveals its chimeric natureLong-term treatment of rheumatoid arthritis with adalimumab.Chemokine-Like Receptor 1 Regulates the Proliferation and Migration of Vascular Smooth Muscle Cells.Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells.CMKLR1 activation ex vivo does not increase proportionally to serum total chemerin in obese humans.Chemotactic cytokines, obesity and type 2 diabetes: in vivo and in vitro evidence for a possible causal correlation?Chemerin regulation and role in host defense.Proteolytic regulatory mechanism of chemerin bioactivity.Adipokines as potential biomarkers in rheumatoid arthritis
P2860
Q22001506-CFFD373F-DDA6-4255-8ED2-E066EF801163Q24309587-5E124A55-EDC1-431C-BE5A-B45769119A0BQ24310805-6B908739-3B44-48C1-9B01-5F0705C1DA45Q24646247-E05C3F59-D5E1-4BC6-A2ED-32636659333FQ24656236-B522BF42-4AE1-4764-A8EF-002B7CC5079EQ24657333-C162F0AC-B9C9-4FCD-ABEB-12CFD79941C4Q26770862-F232E61B-EE75-42DF-BF34-3B8187800F21Q26799489-E258778E-7415-4886-8C96-D1DEB89FB631Q27348572-F7F4260D-BD1B-4909-8C68-64C78AF7C989Q28308192-96FAEF85-225E-4333-9A3C-58B10969DDD0Q28729987-208DB1D9-6C9B-4367-8D0C-291B0268D3B7Q30032660-06322B74-6B39-400A-B699-839A07AFC8FEQ33676679-E22DDF79-6181-43DD-B2CC-2758CF84C1AAQ33824611-03F70A2C-CEDE-4CFC-9FB2-9E4A2F8B50DAQ33849505-86EA99C5-6B22-42A0-A7F8-1BB2A656BB5CQ33858362-54991C6C-CDFA-4F11-A4DC-87CC229689E0Q33882360-97340F83-100D-4995-B54A-F747329BC896Q34328591-8F340A56-6CFB-42FA-B847-BB3FC5B0D395Q34333142-D96E5E42-586B-46DC-9DE1-421A14D30C43Q34507219-06A18AF8-A58D-4B27-8793-0CE15C3C1A5EQ34529446-6EE51C47-E9B9-4F13-A95D-4C9D188BC2D6Q34532701-C3E86D3C-2359-47C7-94E2-0FA64C771D1AQ34542663-F0D9F45C-15CA-46F4-B12F-28FA02FA7ACCQ34548150-87199172-8F27-443B-8102-CE650557450AQ34608852-3FC06D7D-4F6B-4250-AD15-ED78BD6412DEQ34629210-C361D4B2-2D47-425C-B82F-43CD4B6DF4B7Q35081441-B83183CB-E8EB-4736-BA87-FF41EB745DE6Q35604419-93D0C09C-D4F1-4210-B483-5D6B1041CCA3Q35840765-F0DC8C89-4C67-465B-A3B3-8383E7F06E7BQ36157679-E5110D9B-810A-479D-9AA5-28483622F102Q36495510-891567BE-FDC4-40D4-9FCE-C200727C9CAAQ36916411-F1DB2090-C6F1-4AC1-A918-00019A2A2DA9Q37358278-7369044C-1F47-4243-AB8D-888290528F48Q37398587-BFC7EC0D-9955-4595-8B5F-A23EA02F2B7BQ37429204-C5986870-9247-4CDD-B5EF-74E9F4A76512Q37490861-D86D1185-DC38-47A3-AB30-1EE9689A9952Q37583987-32AF05DD-D339-495A-B1B7-EE2A63AA8CEEQ37651088-39DD50C3-0BEE-4545-8729-94B910C3E87AQ37655187-26B0B2A3-6123-4512-A973-36B93FDF9262Q37700750-9C4D7D7B-21DB-436F-9EA7-C2F06BE6EC66
P2860
The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The C-terminal nonapeptide of ...... or with low nanomolar potency.
@ast
The C-terminal nonapeptide of ...... or with low nanomolar potency.
@en
The C-terminal nonapeptide of ...... or with low nanomolar potency.
@nl
type
label
The C-terminal nonapeptide of ...... or with low nanomolar potency.
@ast
The C-terminal nonapeptide of ...... or with low nanomolar potency.
@en
The C-terminal nonapeptide of ...... or with low nanomolar potency.
@nl
prefLabel
The C-terminal nonapeptide of ...... or with low nanomolar potency.
@ast
The C-terminal nonapeptide of ...... or with low nanomolar potency.
@en
The C-terminal nonapeptide of ...... or with low nanomolar potency.
@nl
P2093
P2860
P356
P1476
The C-terminal nonapeptide of ...... tor with low nanomolar potency
@en
P2093
David Communi
Françoise Grégoire
Gilbert Vassart
Patrick Robberecht
Valérie Wittamer
P2860
P304
P356
10.1074/JBC.M313016200
P407
P50
P577
2003-12-29T00:00:00Z